INS and cystic fibrosis: With regard to CFTR potentiators, in CF patients with at least one CFTR conductance or gating mutation, treatment with ivacaftor significantly improved their insulin response, particularly during the early phase of insulin secretion, suggesting that these drugs could improve glucose tolerance in CF patients [50,51].